Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) — Stella

Recruiting

Back to Relapsed / Refractory Osteosarcoma trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

UCLA, Los Angeles, California

Key details

Phase

Early testing / Safety & dosing

Sponsor

Lantheus Medical Imaging

Enrollment target

~55 participants

Started

February 2026

Primary completion

August 2027

Age range

12 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov